AAGH — America Great Health
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1098009 ·
Last close
$0.00
Market Cap
—
52W High
$0.00
52W Low
$0.00
ADV30
609,277
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 26,143 | 22,533 | -73,775 | -166,016 | 167,105 | 29,346 | 5,047,740 |
| Dec 2025 | 45,100 | 36,536 | -198,775 | 1,112,684 | 193,105 | 22,904 | 4,908,221 |
| Sep 2025 | 187,559 | 112,679 | -3,384 | -85,363 | 241,296 | 28,079 | 6,070,405 |
| Jun 2025 | 104,530 | 77,416 | -106,243 | -222,196 | 301,817 | 44,056 | 6,045,644 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-352,837
Investing CF
—
Financing CF
$330,693
CapEx
—
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-9,920,040
Inventory
$97,539
Receivables
$0
ST Investments
—
EBIT TTM
$1,004,300
Pretax Income TTM
$638,909
Interest Exp TTM
$365,391
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Jun 2025 | 391,743 | -382,935 | -719,119 | 301,817 | 6,045,644 | -5,661,210 | -332,862 |
| Jun 2024 | 294,670 | -782,700 | -1,220,571 | 323,478 | 5,448,622 | -5,044,650 | -615,627 |
| Jun 2023 | 204,308 | -492,644 | -761,420 | 299,129 | 4,669,965 | -4,296,133 | -389,809 |
| Jun 2022 | 104,648 | -4,734,098 | -4,866,153 | 336,143 | 4,196,624 | -3,801,698 | -1,479,858 |
TTM Snapshot
Revenues TTM
$1,062,916
NetIncome TTM
$-389,839
OpCashFlow TTM
$0
Assets (Latest)
$249,461
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.06T | $1184.63 | — |
| JNJ | JOHNSON & JOHNSON | $644.82B | $267.57 | — |
| ABBV | AbbVie Inc. | $465.26B | $263.29 | — |
| MRK | Merck & Co., Inc. | $368.30B | $149.28 | — |
| NVS | NOVARTIS AG | $276.95B | $145.71 | — |
Recent Insider Activity
No insider activity indexed for this ticker.